SRI to Lead Five-Member California Collaboration for Drug Development | GenomeWeb

NEW YORK, Aug. 1 - SRI International announced today that it will lead a drug development collaboration called PharmaSTART that will assist four California-based institutions in creating drug discovery plans.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.